Skip to content

Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer

Optimizing Topical Pain Control for Breast Cancer Patients Undergoing Pre-operative Radiotracer Injection for Sentinel Lymph Node Mapping

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04822597
Enrollment
167
Registered
2021-03-30
Start date
2021-04-23
Completion date
2022-05-09
Last updated
2023-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Sentinel Lymph Node, Breast Neoplasms, Breast Cancer Female

Keywords

Sentinel Lymph Node Biopsy, Sentinel Lymph Node Mapping, Radioactive Tracer Injection, Nuclear Medicine, Radiocolloid Injection

Brief summary

The purpose of this study is to compare the effectiveness four different pain treatments for the injection of radioactive tracer that women with breast cancer receive for sentinel lymph node biopsies. This study will include women who have been diagnosed with breast cancer and who will be undergoing sentinel lymph node biopsy with a standard injection of radioactive tracer before surgery. A participant's active participation will take place on two separate occasions. In the first occasion, a participant will complete a brief pain assessment on the day of enrollment. The rest of a participant's active participation will take place on one day (the day of surgery) and last approximately 20 minutes, after which active participation will end.

Detailed description

Primary Objective: To test the effectiveness of four alternative approaches to topical anesthesia on pain associated with radiotracer injection for women diagnosed with breast cancer undergoing sentinel lymph node mapping. Secondary Objectives: 1. To assess patient satisfaction with pain control modality for radiotracer injection. 2. To identify barriers to implementation of the different pain control interventions.

Interventions

Lidocaine is a local anesthetic.

DEVICEBuzzy(R)

Buzzy provides non-invasive pain relief by vibrating and cooling the skin which distracts from pain sensations.

Ice cools the skin and can provide some numbing for pain.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

Data will be analyzed with intervention arms masked.

Intervention model description

There will be four separate treatment arms. Participants have equal chances of being assigned to any of the four arms.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* greater than or equal to 18 years of age * biopsy proven breast cancer * standard radiotracer injection (intradermal injection in the upper outer quadrant of the involved breast) * radiotracer injection occurs on the same day as sentinel lymph node surgery

Exclusion criteria

* males * pregnancy * local anesthetic allergy or active use of the following medications: * Abametapir (risk X) * Conivaptan (risk X) * Fusidic Acid (risk X) * Idelalisib (risk X) * Mifepristone (risk D) * Stiripentol (risk D) * Amiodarone (risk C) * Dofetilide (risk C) * Dronedarone (risk C) * Ibutilide (risk C) * Sotalol (risk C) * Vernakalant (risk C) * Non-English speaking/reading * Unable to provide informed consent * Unable to participate with surveys * Undergoing radiotracer injection the day prior to surgery or intra-operatively at the time of initial surgical scheduling * If patients are initially scheduled for same-day preoperative injection, complete all enrollment procedures (including randomization), and surgery is re-scheduled for a day prior to surgery or for intra-operative injection, they will be excluded if: * randomized to a lidocaine patch arm (Arms C or D) * re-scheduled for an intra-operative injection • Planned non-standard radiotracer injection site

Design outcomes

Primary

MeasureTime frameDescription
Median Post-Procedural Pain ScoreDay of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injectionPost-procedural pain score on the Wong-Baker FACES scale. Scale from 0-10 with 0 being no pain and 10 being worst pain.

Secondary

MeasureTime frameDescription
Short Form McGill Affective Pain ScoreDay of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injectionAffective pain score out of 12 with 0 being no pain and 12 being severe affective pain
Short Form McGill VAS Pain ScoreDay of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injectionVisual analog scale pain score out of 100 with zero being no pain and 100 being worst possible pain
Short Form McGill Combined Pain ScoreDay of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injectionCombination of outcomes 2-3. Additive total score between 0 and 45 with zero being no pain and 45 being severe pain
Degree of Participant Satisfaction With Attention Paid to Complaints as Reported by Number of Participants Who Report Satisfied or Very SatisfiedDay of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection1-6 scale with 1 being very satisfied and 6 being very dissatisfied. Reported are the number of participants satisfied or very satisfied.
Degree of Participant Satisfaction With Care Provided During Injection as Reported by Number of Participants Who Report Satisfied or Very SatisfiedDay of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection1-6 scale with 1 being very satisfied and 6 being very dissatisfied. Reported are the number of participants satisfied or very satisfied.
Degree of Participant Satisfaction With Pain Control as Reported by Number of Participants Who Report Satisfied or Very SatisfiedDay of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection1-6 scale with 1 being very satisfied and 6 being very dissatisfied. Reported are the number of participants satisfied or very satisfied.
Short Form McGill Sensory Pain ScoreDay of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injectionSensory pain score out of 33 with 0 being no pain and 33 being severe sensory pain
Recommendation of Pain Control Modality as Measured by Number of Participants Who Answered YesDay of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injectionYes, No, Not sure with option for free response
Provider Perceived Ease of AdministrationDay of surgery (last of two study visits), assessed within 30 minutes of radioactive tracer injection7 point single ease question to rate ease of a task. 1 being very difficult and 7 being very easy. This is the provider's perception of the how easy the intervention was to administer.
Provider Perceived Participant PainDay of surgery, assessed within 30 minutes of radioactive tracer injection11 point numeric rating scale for perceived pain of others. 0 being no pain and 7-10 being severe pain.
Provider Rank Ordering Ease of Use of InterventionsAssessed after last participant off study (up to 12.5 months)End of study survey to compare providers' perceived usability of intervention. Rank ordering of interventions 1-4 with 1 being easiest to administer and 4 being hardest to administer.
Provider Rank Ordering Perceived Efficacy of InterventionsAssessed after last participant off study (up to 12.5 months)End of study survey to compare providers' perceived efficacy of intervention. Rank ordering of interventions 1-4 with 1 being best pain control and 4 being least pain control.
Degree of Anxiety During the Injection as Measured by Number of Participants Moderately AnxiousDay of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection1-4 scale with 1 being very anxious and 4 being not at all anxious, reported here are the number of participants rating anxiety at 2 or moderate.

Countries

United States

Participant flow

Recruitment details

Participants from the UW Hospital and Clinics were enrolled from April 2021 to January 2022.

Participants by arm

ArmCount
Ice Pack
Ice will be placed on the breast prior to radioactive tracer injection (usual treatment)
44
Buzzy(R)
A vibrating distraction device (Buzzy(R)) and ice will be placed on the breast prior to radioactive tracer injection.
39
Lidocaine Patch
A lidocaine patch (4% topical) will be placed on the breast for at least one hour prior to radioactive tracer injection.
44
Lidocaine Patch and Buzzy(R)
A lidocaine patch (4% topical) will be placed on the breast for at least one hour prior to radioactive tracer injection. This will be removed and a vibrating distraction device (Buzzy(R)) and ice will be placed on the breast just prior to radioactive tracer injection.
40
Total167

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyPhysician Decision0011
Overall StudySubject withdrawn after enrollment0101
Overall StudySurgery Re-scheduled, missed by study team1000
Overall StudyWithdrawal by Subject0110

Baseline characteristics

CharacteristicBuzzy(R)Lidocaine PatchIce PackLidocaine Patch and Buzzy(R)Total
Age, Customized
30-39 years
2 Participants2 Participants2 Participants2 Participants8 Participants
Age, Customized
40-49 years
7 Participants7 Participants6 Participants7 Participants27 Participants
Age, Customized
50-59 years
14 Participants11 Participants6 Participants10 Participants41 Participants
Age, Customized
60-69 years
10 Participants14 Participants16 Participants11 Participants51 Participants
Age, Customized
70-79 years
4 Participants9 Participants14 Participants10 Participants37 Participants
Age, Customized
80-89 years
2 Participants1 Participants0 Participants0 Participants3 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants0 Participants2 Participants0 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
38 Participants43 Participants41 Participants40 Participants162 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants0 Participants2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
2 Participants0 Participants1 Participants1 Participants4 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants1 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
37 Participants44 Participants42 Participants37 Participants160 Participants
Region of Enrollment
United States
39 participants44 participants44 participants40 participants167 participants
Sex: Female, Male
Female
39 Participants44 Participants44 Participants40 Participants167 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 440 / 390 / 440 / 40
other
Total, other adverse events
0 / 440 / 390 / 440 / 40
serious
Total, serious adverse events
0 / 440 / 390 / 440 / 40

Outcome results

Primary

Median Post-Procedural Pain Score

Post-procedural pain score on the Wong-Baker FACES scale. Scale from 0-10 with 0 being no pain and 10 being worst pain.

Time frame: Day of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection

ArmMeasureValue (MEDIAN)
Ice PackMedian Post-Procedural Pain Score2 score on a scale
Buzzy(R)Median Post-Procedural Pain Score2 score on a scale
Lidocaine PatchMedian Post-Procedural Pain Score4 score on a scale
Lidocaine Patch and Buzzy(R)Median Post-Procedural Pain Score4 score on a scale
Secondary

Degree of Anxiety During the Injection as Measured by Number of Participants Moderately Anxious

1-4 scale with 1 being very anxious and 4 being not at all anxious, reported here are the number of participants rating anxiety at 2 or moderate.

Time frame: Day of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ice PackDegree of Anxiety During the Injection as Measured by Number of Participants Moderately Anxious33 Participants
Buzzy(R)Degree of Anxiety During the Injection as Measured by Number of Participants Moderately Anxious24 Participants
Lidocaine PatchDegree of Anxiety During the Injection as Measured by Number of Participants Moderately Anxious32 Participants
Lidocaine Patch and Buzzy(R)Degree of Anxiety During the Injection as Measured by Number of Participants Moderately Anxious25 Participants
Secondary

Degree of Participant Satisfaction With Attention Paid to Complaints as Reported by Number of Participants Who Report Satisfied or Very Satisfied

1-6 scale with 1 being very satisfied and 6 being very dissatisfied. Reported are the number of participants satisfied or very satisfied.

Time frame: Day of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ice PackDegree of Participant Satisfaction With Attention Paid to Complaints as Reported by Number of Participants Who Report Satisfied or Very Satisfied42 Participants
Buzzy(R)Degree of Participant Satisfaction With Attention Paid to Complaints as Reported by Number of Participants Who Report Satisfied or Very Satisfied37 Participants
Lidocaine PatchDegree of Participant Satisfaction With Attention Paid to Complaints as Reported by Number of Participants Who Report Satisfied or Very Satisfied42 Participants
Lidocaine Patch and Buzzy(R)Degree of Participant Satisfaction With Attention Paid to Complaints as Reported by Number of Participants Who Report Satisfied or Very Satisfied37 Participants
Secondary

Degree of Participant Satisfaction With Care Provided During Injection as Reported by Number of Participants Who Report Satisfied or Very Satisfied

1-6 scale with 1 being very satisfied and 6 being very dissatisfied. Reported are the number of participants satisfied or very satisfied.

Time frame: Day of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ice PackDegree of Participant Satisfaction With Care Provided During Injection as Reported by Number of Participants Who Report Satisfied or Very Satisfied42 Participants
Buzzy(R)Degree of Participant Satisfaction With Care Provided During Injection as Reported by Number of Participants Who Report Satisfied or Very Satisfied37 Participants
Lidocaine PatchDegree of Participant Satisfaction With Care Provided During Injection as Reported by Number of Participants Who Report Satisfied or Very Satisfied42 Participants
Lidocaine Patch and Buzzy(R)Degree of Participant Satisfaction With Care Provided During Injection as Reported by Number of Participants Who Report Satisfied or Very Satisfied37 Participants
Secondary

Degree of Participant Satisfaction With Pain Control as Reported by Number of Participants Who Report Satisfied or Very Satisfied

1-6 scale with 1 being very satisfied and 6 being very dissatisfied. Reported are the number of participants satisfied or very satisfied.

Time frame: Day of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ice PackDegree of Participant Satisfaction With Pain Control as Reported by Number of Participants Who Report Satisfied or Very Satisfied33 Participants
Buzzy(R)Degree of Participant Satisfaction With Pain Control as Reported by Number of Participants Who Report Satisfied or Very Satisfied33 Participants
Lidocaine PatchDegree of Participant Satisfaction With Pain Control as Reported by Number of Participants Who Report Satisfied or Very Satisfied36 Participants
Lidocaine Patch and Buzzy(R)Degree of Participant Satisfaction With Pain Control as Reported by Number of Participants Who Report Satisfied or Very Satisfied36 Participants
Secondary

Provider Perceived Ease of Administration

7 point single ease question to rate ease of a task. 1 being very difficult and 7 being very easy. This is the provider's perception of the how easy the intervention was to administer.

Time frame: Day of surgery (last of two study visits), assessed within 30 minutes of radioactive tracer injection

ArmMeasureValue (MEDIAN)
Ice PackProvider Perceived Ease of Administration7 score on a scale
Buzzy(R)Provider Perceived Ease of Administration6 score on a scale
Lidocaine PatchProvider Perceived Ease of Administration7 score on a scale
Lidocaine Patch and Buzzy(R)Provider Perceived Ease of Administration6 score on a scale
Secondary

Provider Perceived Participant Pain

11 point numeric rating scale for perceived pain of others. 0 being no pain and 7-10 being severe pain.

Time frame: Day of surgery, assessed within 30 minutes of radioactive tracer injection

ArmMeasureValue (MEDIAN)
Ice PackProvider Perceived Participant Pain3 score on a scale
Buzzy(R)Provider Perceived Participant Pain3 score on a scale
Lidocaine PatchProvider Perceived Participant Pain4 score on a scale
Lidocaine Patch and Buzzy(R)Provider Perceived Participant Pain3 score on a scale
Secondary

Provider Rank Ordering Ease of Use of Interventions

End of study survey to compare providers' perceived usability of intervention. Rank ordering of interventions 1-4 with 1 being easiest to administer and 4 being hardest to administer.

Time frame: Assessed after last participant off study (up to 12.5 months)

Population: There were 8 providers surveyed to rank the ease of use of the interventions, they were not consented as the IRB considered them 'study team members'

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Ice PackProvider Rank Ordering Ease of Use of Interventions1 - easiest to administer1 Participants
Ice PackProvider Rank Ordering Ease of Use of Interventions27 Participants
Ice PackProvider Rank Ordering Ease of Use of Interventions30 Participants
Ice PackProvider Rank Ordering Ease of Use of Interventions4 - hardest to administer0 Participants
Buzzy(R)Provider Rank Ordering Ease of Use of Interventions20 Participants
Buzzy(R)Provider Rank Ordering Ease of Use of Interventions38 Participants
Buzzy(R)Provider Rank Ordering Ease of Use of Interventions4 - hardest to administer0 Participants
Buzzy(R)Provider Rank Ordering Ease of Use of Interventions1 - easiest to administer0 Participants
Lidocaine PatchProvider Rank Ordering Ease of Use of Interventions30 Participants
Lidocaine PatchProvider Rank Ordering Ease of Use of Interventions21 Participants
Lidocaine PatchProvider Rank Ordering Ease of Use of Interventions4 - hardest to administer0 Participants
Lidocaine PatchProvider Rank Ordering Ease of Use of Interventions1 - easiest to administer7 Participants
Lidocaine Patch and Buzzy(R)Provider Rank Ordering Ease of Use of Interventions4 - hardest to administer8 Participants
Lidocaine Patch and Buzzy(R)Provider Rank Ordering Ease of Use of Interventions20 Participants
Lidocaine Patch and Buzzy(R)Provider Rank Ordering Ease of Use of Interventions1 - easiest to administer0 Participants
Lidocaine Patch and Buzzy(R)Provider Rank Ordering Ease of Use of Interventions30 Participants
Secondary

Provider Rank Ordering Perceived Efficacy of Interventions

End of study survey to compare providers' perceived efficacy of intervention. Rank ordering of interventions 1-4 with 1 being best pain control and 4 being least pain control.

Time frame: Assessed after last participant off study (up to 12.5 months)

Population: There were 8 providers that were not consented to the study because the IRB considered the 'study team members'

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Ice PackProvider Rank Ordering Perceived Efficacy of Interventions22 Participants
Ice PackProvider Rank Ordering Perceived Efficacy of Interventions32 Participants
Ice PackProvider Rank Ordering Perceived Efficacy of Interventions4 - worst pain control2 Participants
Ice PackProvider Rank Ordering Perceived Efficacy of Interventions1 - best pain control2 Participants
Buzzy(R)Provider Rank Ordering Perceived Efficacy of Interventions31 Participants
Buzzy(R)Provider Rank Ordering Perceived Efficacy of Interventions4 - worst pain control1 Participants
Buzzy(R)Provider Rank Ordering Perceived Efficacy of Interventions1 - best pain control2 Participants
Buzzy(R)Provider Rank Ordering Perceived Efficacy of Interventions24 Participants
Lidocaine PatchProvider Rank Ordering Perceived Efficacy of Interventions4 - worst pain control5 Participants
Lidocaine PatchProvider Rank Ordering Perceived Efficacy of Interventions31 Participants
Lidocaine PatchProvider Rank Ordering Perceived Efficacy of Interventions1 - best pain control0 Participants
Lidocaine PatchProvider Rank Ordering Perceived Efficacy of Interventions22 Participants
Lidocaine Patch and Buzzy(R)Provider Rank Ordering Perceived Efficacy of Interventions1 - best pain control4 Participants
Lidocaine Patch and Buzzy(R)Provider Rank Ordering Perceived Efficacy of Interventions34 Participants
Lidocaine Patch and Buzzy(R)Provider Rank Ordering Perceived Efficacy of Interventions20 Participants
Lidocaine Patch and Buzzy(R)Provider Rank Ordering Perceived Efficacy of Interventions4 - worst pain control0 Participants
Secondary

Recommendation of Pain Control Modality as Measured by Number of Participants Who Answered Yes

Yes, No, Not sure with option for free response

Time frame: Day of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ice PackRecommendation of Pain Control Modality as Measured by Number of Participants Who Answered Yes31 Participants
Buzzy(R)Recommendation of Pain Control Modality as Measured by Number of Participants Who Answered Yes31 Participants
Lidocaine PatchRecommendation of Pain Control Modality as Measured by Number of Participants Who Answered Yes35 Participants
Lidocaine Patch and Buzzy(R)Recommendation of Pain Control Modality as Measured by Number of Participants Who Answered Yes35 Participants
Secondary

Short Form McGill Affective Pain Score

Affective pain score out of 12 with 0 being no pain and 12 being severe affective pain

Time frame: Day of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection

ArmMeasureValue (MEDIAN)
Ice PackShort Form McGill Affective Pain Score0 score on a scale
Buzzy(R)Short Form McGill Affective Pain Score0 score on a scale
Lidocaine PatchShort Form McGill Affective Pain Score0 score on a scale
Lidocaine Patch and Buzzy(R)Short Form McGill Affective Pain Score0 score on a scale
Secondary

Short Form McGill Combined Pain Score

Combination of outcomes 2-3. Additive total score between 0 and 45 with zero being no pain and 45 being severe pain

Time frame: Day of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection

ArmMeasureValue (MEDIAN)
Ice PackShort Form McGill Combined Pain Score4 score on a scale
Buzzy(R)Short Form McGill Combined Pain Score3 score on a scale
Lidocaine PatchShort Form McGill Combined Pain Score6 score on a scale
Lidocaine Patch and Buzzy(R)Short Form McGill Combined Pain Score3 score on a scale
Secondary

Short Form McGill Sensory Pain Score

Sensory pain score out of 33 with 0 being no pain and 33 being severe sensory pain

Time frame: Day of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection

ArmMeasureValue (MEDIAN)
Ice PackShort Form McGill Sensory Pain Score1 score on a scale
Buzzy(R)Short Form McGill Sensory Pain Score1 score on a scale
Lidocaine PatchShort Form McGill Sensory Pain Score2 score on a scale
Lidocaine Patch and Buzzy(R)Short Form McGill Sensory Pain Score2 score on a scale
Secondary

Short Form McGill VAS Pain Score

Visual analog scale pain score out of 100 with zero being no pain and 100 being worst possible pain

Time frame: Day of surgery (last of two study visits), assessed within 3 hours of radioactive tracer injection

ArmMeasureValue (MEDIAN)
Ice PackShort Form McGill VAS Pain Score24 score on a scale
Buzzy(R)Short Form McGill VAS Pain Score28 score on a scale
Lidocaine PatchShort Form McGill VAS Pain Score27 score on a scale
Lidocaine Patch and Buzzy(R)Short Form McGill VAS Pain Score33 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026